X
Pharma Advancement
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Merck to Acquire Verona

    Merck to Acquire Verona Pharma in $10B Deal Boosts COPD Drug

    Emerging Oral Small Molecule Drugs

    Emerging Oral Small-Molecule Drugs for Ultra-Rare Diseases

    FDA Approves Oral Therapy for Treating Hereditary Angioedema

    FDA Approves Oral Therapy for Treating Hereditary Angioedema

    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Merck to Acquire Verona

    Merck to Acquire Verona Pharma in $10B Deal Boosts COPD Drug

    Emerging Oral Small Molecule Drugs

    Emerging Oral Small-Molecule Drugs for Ultra-Rare Diseases

    FDA Approves Oral Therapy for Treating Hereditary Angioedema

    FDA Approves Oral Therapy for Treating Hereditary Angioedema

    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home News

A NIH Study Ties COVID Vaccine To Increased Menstrual Cycle

Content Team by Content Team
30th September 2022
in News, Research & Development
A NIH Study Ties COVID Vaccine To Increased Menstrual Cycle

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

An extensive worldwide study supported by the National Institutes of Health found a modest increase in the length of a woman’s menstrual cycle after receiving the COVID-19 vaccine, which delayed the onset of bleeding by a few hours.

The NIH’s child health and human development institute’s director, Dr. Diana Bianchi, stated that the alterations brought on by vaccination seem minor, transient, and within the usual range. According to the health service, the extended menstrual cycle, which is generally approximately a month long, did not exactly raise the number of days of bleeding.

According to the NIH, a change in menstrual cycle duration of eight days or less is seen as falling within the normal range of variation. The study’s results showed that participants’ menstrual cycles lengthened on average by.71 days, or even less than 24 hours, after the first vaccine dosage and by a little over half a day after the second dose. When both vaccine doses were given to a woman at once, her cycle lengthened by 3.91 days.

But more than 1,300 women, or 6.2% of the study’s vaccinated subjects and 5% of the unvaccinated, experienced a period lengthening of eight days or more. A larger delay in the start of periods was more likely to be observed among younger women who experienced a longer cycle prior to immunisation.

For women who got one dosage per menstrual cycle and within roughly 20 hours for those who got both doses in a single period, cycle duration had mostly reverted to normal following the immunisation series. The study included around 20,000 participants from Canada, the U.K., the U.S., Europe, and other countries. Moderna, Pfizer-BioNTech, Johnson & Johnson, AstraZeneca, Sputnik, Covishield, Covaxin, Sinopharm, and Sinovac were among the nine vaccinations administered to participants.

The length of the menstrual cycle did not change differently between vaccinations.

The researchers used information from the Natural Cycles fertility tracking app. Women gave the app data about their body temperature and menstrual length. Users of the app have the choice to opt-out of their personally identifying information being used to identify them when they contribute their data for research.

The study presented this week validated the preliminary findings that had been published in January, revealing a connection between COVID immunisation and lengthened menstrual cycles. Five research organisations received $1.67 million from the NIH to study the problem.

Previous Post

Indian Biotech Needs Faster Regulatory Processes- Report

Next Post

DEKRA Is Chosen By MHRA To Accredit Medical Devices In UK

Related Posts

Merck to Acquire Verona
Drug Development

Merck to Acquire Verona Pharma in $10B Deal Boosts COPD Drug

21st July 2025
ChiRhoClin LogiCare3PL Partners for Drug Distribution
News

ChiRhoClin, LogiCare3PL Partners for Drug Distribution

21st July 2025
Emerging Oral Small Molecule Drugs
Drug Development

Emerging Oral Small-Molecule Drugs for Ultra-Rare Diseases

21st July 2025
Thermo Fisher and Sanofi Partners
Manufacturing

Thermo Fisher and Sanofi Partners for US Drug Manufacturing

21st July 2025
EMA Recommendations to Secure Anti D Immunoglobulins Supply
News

EMA Recommendations to Secure Anti-D Immunoglobulins Supply

15th July 2025
FDA Approves Oral Therapy for Treating Hereditary Angioedema
FDA Approvals

FDA Approves Oral Therapy for Treating Hereditary Angioedema

15th July 2025
Next Post

DEKRA Is Chosen By MHRA To Accredit Medical Devices In UK

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In